This brief review covers the evolving clinical role of paramagnetic contrast agents in magnetic resonance imaging of the central nervous system, with particular emphasis on potential pitfalls. The safety and efficacy of Gd-DTPA is now well-established. Approximately 35-40% of all scans performed in this country now utilize the agent. The major pitfalls center on overinterpretation of the characterization of disease by either enhancement or lack thereof in any particular process.
No takes yet. Share an insight, caveat, or question.
Michael Brant‐Zawadzki (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: